Skip to main content

Published locations for CUDC-907 enters phase II for relapsed or refractory lymphoma and multiple myeloma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CUDC-907 enters phase II for relapsed or refractory lymphoma and multiple myeloma

User login

  • Reset your password
  • /content/cudc-907-enters-phase-ii-relapsed-or-refractory-lymphoma-and-multiple-myeloma
  • /hematologynews/article/107985/indolent-lymphoma/cudc-907-enters-phase-ii-relapsed-or-refractory
  • /oncologypractice/article/107985/indolent-lymphoma/cudc-907-enters-phase-ii-relapsed-or-refractory
  • /hematologynews/nhlhub/article/107985/indolent-lymphoma/cudc-907-enters-phase-ii-relapsed-or
  • /hematology-oncology/article/107985/indolent-lymphoma/cudc-907-enters-phase-ii-relapsed-or-refractory
  • /b-cell-lymphoma-icymi/article/107985/indolent-lymphoma/cudc-907-enters-phase-ii-relapsed-or